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13 ABSTRACT: Avian inﬂuenza A viruses, which can also propagate between humans,
14 present serious pandemic threats, particularly in Asia. The speciﬁcity (selectivity) of
15 interactions between the recognition protein hemagglutinin (HA) of the virus capsid
16 and the glycoconjugates of host cells also contributes to the eﬃcient spread of the
17 virus by aerosol between humans. Some avian origin viruses, such as H1N1 (South
18 Carolina 1918), have improved their selectivity for human receptors by mutation in
19 the HA receptor binding site, to generate pandemic viruses. Molecular details and
20 dynamics of glycan−HA interactions are of interest, both in predicting the pandemic
21 potential of a new emerging strain and in searching for new antiviral drugs. Two
22 complementary techniques, 1H saturation transfer diﬀerence (1H STD) nuclear
23 magnetic resonance and molecular dynamics (MD) simulation, were applied to
24 analyze the interaction of the new H7 (A/Anhui/1/13 H7N9) with LSTa [Neu5Ac
25 α(2→3) Gal β(1→3) GlcNAc β(1→3) Gal β(1→4) Glc] and LSTc [Neu5Ac α(2→
26 6) Gal β(1→4) GlcNAc β(1→3) Gal β(1→4) Glc] pentasaccharides, models of avian and human receptor glycans. Their
27 interactions with H7 were analyzed for the ﬁrst time using 1H STD and MD, revealing structural and dynamic behavior that
28 could not be attained from crystal structures, and contributing to glycan−HA speciﬁcity. This highlighted aspects that could
29 aﬀect glycan−HA recognition, including the mutation H7 G228S, which increases H2 and H3 speciﬁcity for the human receptor.
30 Finally, interactions between LSTc and H7 were compared with those between LSTc and H1 of H1N1 (South Carolina 1918),
31 contributing to our understanding of the recognition ability of HAs.
32 In 2013, a new inﬂuenza A subtype was able to diﬀuse rapidly33 through the human population in eastern China. Initially,
34 three people in the urban area of Shanghai and Anhui were
35 hospitalized with rapidly progressing lower respiratory tract
36 infections and were found to be infected by the novel avian
37 origin inﬂuenza A virus H7N9. This virus showed peculiar
38 properties compared to known similar subtypes, particularly in
39 its propensity to mutate. The transmission of H7 virus rarely
40 involves mammals, while infections of the N9 type viruses in
41 humans had never been observed before.1 A prerequisite for an
42 avian inﬂuenza virus to become pandemic is its ability to be
43 transmitted eﬃciently in humans by aerosol diﬀusion, and not
44 to rely on contact between individuals or biological ﬂuids, as
45 was the case for the avian virus infecting birds.2 The molecular
46 mechanisms by which some animal inﬂuenza viruses during
47 their evolution began to propagate in humans have not yet
48 been thoroughly investigated, while this information may prove
49 to be crucial in the design of antiviral drugs and to our ability to
50predict their pandemic potential. The interaction between the
51viral capsid protein hemagglutinin (HA) and the glycan
52receptors on the host cell surface is an important event in
53the early stage of the infection, which determines the
54recognition of target cells by the virus,3 and was shown to be
55the basis of virus aerosol transmissibility between humans. As
56an example, the H1N1 virus responsible for the 1918 “Spanish
57ﬂu” pandemic (SC18, “South Carolina 1918”) propagated as
58eﬃciently between ferrets by aerosol as it did between humans,
59but a single mutation (D225G) and a double mutation
60(D225G/D190E) of amino acids in the H1 receptor binding
61site (RBS) yielded two artiﬁcial viruses, NY18 and AV18,
62respectively, the former being transmitted ineﬃciently and the
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63 latter unable to do so; its lethality and replication activity were
64 preserved.4 Interestingly, this change in H1N1 virus trans-
65 mission, correlated with a binding speciﬁcity switch of H1, from
66 human to avian glycan receptors. In fact, SC18 binds selectively
67 to the human receptor, NY18 interacts with both human and
68 avian receptors, while the double mutant AV18 binds selectively
69 to the avian receptor.5 The avian and human receptors are
70 glycan chains “end-capped” by Neu5Ac α(2−3) Gal and
71 Neu5Ac α(2−6) Gal disaccharides, respectively, being
72 frequently found in the intestinal epithelia of birds and on
73 epithelial cells of the upper respiratory tract of humans, these
74 two being the target tissues for avian and human inﬂuenza virus
75 infection, respectively.3 Two model pentasaccharides are
76 commonly used for avian and human glycan receptor, whose
77 primary structure is deﬁned as LSTa [α-D-Neu5Ac (2→3) β-D-
78 Gal (1→3) β-D-GlcNAc (1→3) β-D-Gal (1→4) β-D-Glc] and
79 LSTc [α-D-Neu5Ac (2→6) β-D-Gal (1→4) β-D-GlcNAc-(1→3)
80 β-D-Gal (1→4) β-D-Glc]. Avian and human HAs recognize
81 their receptors through the exposed nonreducing terminal end,
82 characterized by a diﬀerent conformation and dynamics in
83 solution.6−8 At the molecular level, the H1 (SC18) speciﬁcity
84 switch was explained by observing that the D225G mutation on
85 H1 removed crucial hydrogen bonds between the RBS and the
86 LSTc nonreducing end,5,8,9 while the additional mutation
87 (D190E) further reduced the extent of contact between its
88 reducing end and the surface of helix 190.8−10 In contrast, E190
89 (AV18) was found to interact more eﬃciently than D190 with
90 Neu5Ac α(2−3) Gal of LSTa, because of its longer side chain,8
91 as previously postulated by Gamblin et al.9 and Srinivasan et al.5
92 Other HA subtypes showed changes in their binding speciﬁcity
93 following only minor amino acid mutations, including H2 and
94 H3 from H2N2 and H3N2 avian viruses responsible for the
95 pandemic events of 1957 and 1968, respectively. These subtype
96 HAs, through the Q226L and G228S mutations, changed their
97 preference from avian to human receptors.10 In addition, H7
98 from H7N9 virus, by analogy with H2 and H3, includes the
99 Q226L mutation11 in some variants (A/Anhui/1/13), con-
100 tributing to its aﬃnity for human receptors.2,12
101 In 2013, Xiong et al.13 compared an avian H7 from H7N3
102 (A/turkey/Italy/214845/2002) with the human H7 of H7N9
103 (A/Anhui/1/13), using biolayer interferometry to measure
104 their binding aﬃnity with α(2−3) and α(2−6) sialyl lactos-
105 amines. The observed H7s diﬀer by two amino acids, Q226L
106 and G186V, with the human H7 having an aﬃnity comparable
107 to those of both human and avian receptors. In late 2013, an
108 investigation involving two H7 variants isolated from humans,
109 A/Anhui/1/13 (AH-H7N9) and A/Shanghai/1/13 (SH-
110 H7N9), revealed how SH-H7N9, characterized by the “avian
111 signature” Q226, bound the avian receptors preferentially while
112 AH-H7N9, which contained the “human signature” L226, could
113 bind both avian and human receptors with comparable
114 aﬃnity.14 These results conﬁrmed the weak speciﬁcity of this
115 H7 variant for the human and avian receptors.
116 In this study two complementary techniques, 1H STD NMR
117 and MD simulation were applied for the ﬁrst time to
118 characterize the interaction between LSTa and LSTc, with
119 H7 (AH-H7N9) in solution, underlining the structural and
120 dynamic properties responsible for the molecular recognition
121 ability of H7, and glycan residues, which cannot be resolved by
122 X-ray diﬀraction because of the ﬂexibility of the glycan.2 The
123 pentasaccharides LSTa and LSTc were used as models for avian
124 and human glycan receptors. The same approach was then
125 applied to predict the eﬀect of a single G228S mutation on H7
126aﬃnity and binding epitopes toward LSTa and LSTc, a
127structural biology problem that has been considered only
128partially in the characterization of this new HA subtype. In fact,
129considering the similarity of H7 to H2 and H3 subtypes, the
130selected mutation might have been expected to switch its
131speciﬁcity toward the human receptor (LSTc), pushing the
132virus to infect humans. Tissue binding tests suggest that H7
133aﬃnity improvements can occur to both glycans following
134mutation, without aﬀecting speciﬁcity.15 The same result was
135conﬁrmed by glycan microarray and kinetic analysis for H7 of
136the SH-H7N9 variant16 and later, during the preparation of this
137work, by a solid phase binding assay using α(2−3) or α(2−6)
138sialyl-lactosamines on H7 of AH-H7N9 virus.17 This mutation
139was expected to reinforce H7 binding for both glycans, with the
140hydroxyl moiety of the serine side chains interacting with the
141sialyl groups of LSTc and LSTa, through the formation of
142hydrogen bonds. Competitive 1H STD experiments involving
143an equimolar mixture of LSTc and LSTa interacting with H7sm
144(H7G228S) qualitatively suggest for H7sm a weak preference
145for LSTa. In the ﬁnal part of this paper, LSTc:H7 and LSTc:H1
146(H1N1 South Carolina 1918) complexes are compared, using
147the 1H STD/MD approach. This revealed fundamental
148structural and dynamic diﬀerences between H7 and H1,
149providing distinct ways to recognize the human receptor
150LSTc, a comparison that, until now, has not been discussed
151extensively.
152■ MATERIALS AND METHODS
153Respiratory Tract Glycan Receptors. The H7 ligands
154chosen for the 1H STD experiments on H7 and H7sm were
155pentasaccharide mimetics for avian and human cell surface
156glycan receptors, whose primary structure is deﬁned as α-D-
157Neu5Ac (2→6) β-D-Gal (1→4) β-D-GlcNAc (1→3) β-D-Gal
158(1→4) β-D-Glc for the human receptor (LSTc) and α-D-
159Neu5Ac (2→3) β-D-Gal (1→3) β-D-GlcNAc (1→3) β-D-Gal
160(1→4) β-D-Glc for the avian receptor (LSTa). In this work, the
161residue sequence from the nonreducing (NRE) to reducing end
162(RE) was labeled a follows: (NRE) Neu5Ac Gal-1 GlcNAc Gal-
1632 Glc (RE), where “-N” speciﬁes the “Gal” residue numbered
164sequentially from the NRE. LSTa and LSTc were purchased
165from Prozyme (Hayward, CA) and Dextra (Reading, U.K.),
166respectively.
167Cloning, Baculovirus Synthesis, and Mammalian
168Expression and Puriﬁcation of HA. H7 (AH-H7N9) and
169the mutated H7sm sequences were codon-optimized for
170mammalian expression, synthesized with a foldon sequence
171and six-His tag at the C-terminus (DNA2.0, Menlo Park, CA),
172and subcloned into a modiﬁed pcDNA3.3 vector for expression
173under the CMV promoter. Recombinant expression of HA was
174performed in HEK 293-F FreeStyle suspension cells (In-
175vitrogen, Carlsbad, CA) cultured in 293-F FreeStyle Expression
176Medium (Invitrogen) maintained at 37 °C, 80% humidity, and
1778% CO2. Cells were transfected with polyethyleneimine Max
178(PEI-MAX, PolySciences, Warrington, PA) with the HA
179plasmid and were harvested 7 days postinfection. The
180supernatant was collected by centrifugation, ﬁltered through a
1810.45 μm ﬁlter system (Nalgene, Rochester, NY), and
182supplemented with 1:1000 diluted protease inhibitor cocktail
183(Calbiochem) and supplemented with 1:1000 diluted protease
184inhibitor cocktail (EMD Millipore). HA was puriﬁed from the
185supernatant using His-trap columns (GE Healthcare) on an
186AKTA Puriﬁer FPLC system. Eluting fractions containing HA
187were pooled, concentrated, and buﬀer exchanged into 1× PBS
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188 (pH 7.4) using 100K molecular weight cutoﬀ spin columns
189 (Millipore, Billerica, MA). The puriﬁed protein was quantiﬁed
190 using the BCA method (Pierce, Rockford, IL). The
191 recombinant HA was expressed and puriﬁed as HA0 and ran
192 as a single band on sodium dodecyl sulfate−polyacrylamide gel
193 electrophoresis. The HA was not cleaved into HA1 and HA2.
194 The HA yield was 1 mg/mL.
195 NMR Analysis of the Interaction of H7 and H7sm with
196 LSTc and LSTa. 1H STD NMR samples were prepared by
197 washing proteins H7 and H7sm (1 mg/mL) with a buﬀered
198 solution [150 mM sodium chloride, 100 mM sodium
199 phosphate, 0.3 mM d-EDTA, and D2O (pH 7.2) (Sigma-
200 Aldrich)] using Amicon Ultra centrifugal ﬁlters and a 10 kDa
201 membrane (Millipore). Each ligand (LSTc or LSTa) was added
202 to the corresponding protein sample, reaching a ﬁnal molar
203 ratio of 100:1 (glycan receptor:HA) for the 1H STD
204 measurements. For the competitive experiment, to 200 μg of
205 the ﬁrst ligand (100:1) was added an additional 200 μg of the
206 second ligand in the NMR tube. The protein concentration for
207 the 1H STD measurements was 0.01 mM. NMR spectra were
208 recorded using Bruker 600 and 900 MHz AVANCE series
209 NMR spectrometers, both equipped with high-sensitivity 5 mm
210 TCI cryoprobes. LSTc and LSTa resonances have been
211 reported by Sassaki et al.7 For the STD experiments, the on-
212 resonance frequency was set at 7.3 ppm and the oﬀ-resonance
213 frequency at 20.0 ppm, a train of 40 Gaussian-shaped pulses of
214 50 ms each were applied to produce a selective saturation of 2 s,
215 while D1 was set to 6 s. The number of scans was 1K or 2K,
216 and the spectral width was 12626 Hz. The spectra were
217 recorded at 295 K.
218 Molecular Dynamics Simulations. The interactions
219 between LSTa and LSTc and H7 hemagglutinin (AH-H7N9)
220 and its mutant version, H7sm, were also investigated by
221 comparing the MD simulation trajectories of the following
222 complexes: LSTa:H7 with LSTc:H7 and LSTa:H7sm with
223 LSTc:H7sm. Model complexes LSTa:H7 and LSTc:H7 were
224built from the corresponding X-ray diﬀraction structures
225[Protein Data Bank (PDB) entries 4BSF and 4BSE], where
226the known conformations of LSTa and LSTc, predicted by
227Sassaki et al. using the NMR/MD approach,7 were super-
228imposed on the corresponding α(2−3) and α(2−6) sialyl-
229lactosamine trisaccharides resolved together with the protein.
230The glycan:H7 complexes were built to reproduce as much as
231possible the proper solution environment conformations; in
232fact, the two glycans in their bound states with H18,18 and H319
233HA were found to be qualitatively similar to their
234corresponding free states in terms of glycosidic backbone
235conformation.7,20 Compared to the nonreducing end dis-
236accharide (Neu5Ac-Gal-1), the minimal root-mean-square
237distances upon superimposition were 1.53 and 2.92 Å for
238Neu5Ac and Gal-1, respectively, in the LSTa:H7 complex and
2391.12 and 1.93 Å, respectively, measured in the LSTc:H7
240complex. In these complexes, only the amino acids forming the
241H7 RBS structure (from 51 to 251 of 4BSF and 4BSE13) were
242considered. The LSTa:H7sm and LSTc:H7sm complexes were
243generated from the LSTa:H7 and LSTc:H7 complexes,
244respectively, by applying a “virtual” mutation, G228S; under
245this condition, the structure surrounding each ligand was
246preserved. The LSTc:H1 model complex was prepared using
247the same approach, but starting from PDB entry 2WRG,
248including H1 hemagglutinin of H1N1 South Carolina 1918
249(SC18), together with four residues of LSTc in H1 RBS, as
250previously described by Elli et al.8 Ambertools 1.421 was used to
251build the GLYCAM0622/Amber force ﬁeld for MD simulation
252of the glycan and protein part of the complexes. The simulation
253cell was set by enveloping each macromolecule with a water
254layer (TIP3P23) 15 Å wide in the three directions, resulting in
255an orthogonal cell with edge lengths of approximately 100 Å.
256The nonbonded potential energy was described using the
257standard cutoﬀ technique (12 Å) for both electrostatic and
258dispersive interactions. Each cell was minimized using 100K
259steps of the default minimization algorithm included in the
Figure 1. 600 MHz 1H STD NMR spectra of the LSTa:H7 (green lines in panels a and b) and LSTc:H7 (green lines in panels c and d) complexes,
superimposed on the corresponding reference spectra (black lines), and on the respective HSQC spectra of LSTa and LSTc. Labels indicate the
unequivocally assigned signals. Insets in panels b and d show the N-acetyl STD signals of LSTa:H7 and LSTc:H7 receptor complexes, respectively.
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260 NAMD 2.1024 simulation engine. All the MD simulations were
261 conducted sampling the NPT ensemble for the whole length,
262 even if cell density equilibration required approximately 1 ns.
263 The simulation temperature was set at 300 K and maintained
264 by a Langevin thermostat as implemented in NAMD 2.10,
265 while the Nose−́Hoover Langevin piston algorithm controlled
266 the pressure (1.01325 bar) applied on the cell walls. During the
267 minimization and cell density equilibration steps (1 ns), a
268 harmonic potential energy restraint was applied (harmonic
269 constant of 50 kcal mol−1) to all atoms of the complex, while
270 water molecules were allowed to move freely. The MD
271 simulation duration was approximately 150 ns for all cases, and
272 the HA RBS sequence surrounding the glycan (residues 86−
273 101 and 121−224 for H7 and residues 95−110 and 130−233
274 for H1) was left free to move. Soft harmonic restraints on the
275 HA backbone atoms (Cα, N, and carbonyl carbon) with a
276 harmonic constant of 2.0 kcal mol−1 were applied to the
277 remaining sequence, to maintain the secondary and tertiary
278 structure of the HA RBS. The MD simulation trajectory was
279 sampled every 10 ps, and the comparisons between the
280 diﬀerent complexes were conducted by monitoring selected
281 distances between the ligand and the HA RBS residues, or by
282 images obtained by superimposing snapshots at signiﬁcant
283 simulation times. This allowed the ligand−HA dynamics to be
284 visualized and the binding state to be compared. The molecular
285 visualization, structural analysis, and MD simulation trajectory
286 analysis were undertaken using VMD 1.9.2.25 RMSD functions
287 were calculated using the RMSDTT (Root Mean Square
288 Distance Trajectory Tool) plug-in included in VMD 1.9.2. The
289 two-dimensional (2D) histograms of the glycosidic dihedral
290 angles were calculated using R.26
291 ■ RESULTS
292 NMR Analysis of Glycan−HA Interactions. 1H STD
293 experiments allowed the mapping of the 1H-interacting epitope
294of both human and avian receptors with the tested HAs (the
295full 1H and 13C assignments of LSTc and LSTa have been
296published elsewhere7,8). The 1H STD spectra of LSTa and
297LSTc in the bound state with H7 HA were recorded at 600
298 f1MHz and are reported in Figure 1 (panels a−d, respectively).
299The analysis of these spectra revealed that the two glycans
300interact with H7, primarily through their nonreducing terminal
301Neu5Ac residue (H4, H5, H7, and H9). In addition to the
302nonreducing end moiety Neu5Ac, LSTa also interacts with H7
303HA through H3 and H4 of Gal-1 and H2 of Gal-2.
304Unfortunately, because of the overlap of the signals of the
305CH3 belonging to Neu5Ac and GlcNAc, it was not possible to
306resolve which of these groups were involved more closely in the
307interaction (Figure 1b). Whereas LSTc bound H7 HA using
308mainly H6−H9 of NeuAc and also H1 and H4 of Gal-1 and
309Gal-2, these latter STD signals appeared to be weaker than the
310Neu5Ac resonances (Figure 1c). In this case, it was possible to
311distinguish between the two methyl groups (Figure 1d). In fact,
312only the methyl group of Neu5Ac appeared in the 1H STD
313spectrum of the LSTc:H7 complex, indicating its proximity to
314the RBS of the protein. This methyl group was likely to be
315facing toward W153 and the three preserved residues, Y98,
316H183, and L194, which are located at the bottom of the RBS.
317The qualitative interpretation of 1H STD NMR spectra of the
318LSTa:H7 complex showed that the binding epitope is mainly
319represented by the nonreducing end disaccharide Neu5Ac
320α(2−3) Gal-1. In contrast for the LSTc:H7 complex, a strong
321STD signal originating from H2 of Gal-2 suggests the
322involvement of the LSTa reducing end, certainly Gal-2 and
323possibly GlcNAc residues, in the binding epitope.
324The STD NMR glycan−HA interaction studies were also
325performed on the single mutant H7G228S (H7sm). The
326comparison of STD spectra with those obtained with the wild
327type form of H7 revealed changes in the glycan binding
328 f2epitopes correlated to the protein mutation (Figure 2). The 1H
Figure 2. 900 MHz 1H STD NMR spectra of LSTa:H7sm and LSTc:H7sm (red lines in panels a−d) complexes, superimposed on the
corresponding 1H STD spectra of LSTa:H7 and LSTc:H7 (black lines) complexes and on the HSQC spectra of LSTa and LSTc. Labels indicate the
unequivocally assigned signals. Insets in panels b and d show the N-acetyl regions of the overlaid 1H STD HSQC spectra of LSTa:H7sm and
LSTc:H7sm receptor complexes, respectively.
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Figure 3. MD-simulated (a) LSTc:H7 and (b) LSTa:H7 complexes at 120, 130, 140, and 150 ns superimposed on the H7 backbone (Cα). The
white ribbon shows the H7 amino acid sequence allowed to move freely around the glycan, while the orange ribbon indicates the sequence restrained
by a soft harmonic potential applied to the protein backbone. The two ribbons superimposed corresponded to 120 and 150 ns snapshots. The thin
yellow tubes represent the X-ray-resolved trisaccharides: Neu5Ac α(2−6) Gal-1 GlcNAc (left) and Neu5Ac α(2−3) Gal-1-GlcNAc (right)
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329 STD spectra of the LSTa:H7sm and LSTa:H7 complexes
330 showed a similar proﬁle (Figure 2a,b), indicating that the
331 interaction involved mainly the Neu5Ac residue, and partially
332 Gal-1 and Gal-2. However, STD signals from H3 and H4 of
333 Gal-1 (weak and medium intensity, respectively) detected in
334 the LSTa:H7 complex were weaker in the LSTa:H7sm complex
335 (H3 of Gal-1 just detected) (Figure 2a). Interestingly, upon H7
336 mutation, two weak STD signals appeared, H2 Gal-1 and H2
337 Glc, also indicating the partial involvement of the LSTa
338 reducing end in the interaction. Similar to what was observed
339 with the H7 wild type, the human receptor LSTc interacts with
340 H7sm mainly through the Neu5Ac residues (Figure 2c). In
341 contrast, in the 1H STD spectra of the LSTc:H7sm complex, a
342 weak STD signal belonging to H2 of Gal-1 was detected, while
343 the signal originating from the CH3 of the GlcNAc (Figure 2d)
344 was weaker in comparison with that of the LSTc:H7 complex,
345 suggesting a weak contact between GlcNAc and H7sm RBS.
346These results indicated a small but signiﬁcant diﬀerence in
347terms of binding epitope between the two glycans in the bound
348state with H7 and H7sm, which is supported qualitatively by
349the modeling description in the following section.
350To qualitatively compare the aﬃnity of LSTa and LSTc for
351H7sm, a competitive 1H STD experiment was designed in
352which a sample containing H7sm and an equal amount of LSTa
353and LSTc glycans were mixed (Figure S1). In the interacting
354mixture, the 1H STD signals belonging to LSTa in Figure S1
355appear slightly stronger than those of LSTc, suggesting that
356H7sm preferentially binds the avian receptor (LSTa). These
357results are in accord with the glycan microarray and kinetic
358results of Yang et al.16 (compare Figure 2B with Figure 8A,
359Figure B with Figure 8B, and also Table 5 with Table 6 of Yang
360et al.). The kinetic, glycan microarray,16 and solid surface
361binding17 assays support an improvement in the aﬃnity of H7
362for both human and avian receptor mimetics upon G228S
Figure 3. continued
cocrystallized with H7 (H7N9, PDB entries 4BSE and 4BSF). The amino acid residues forming the H7 RBS bottom (Y98, W153, H183, L194, and
Y195) and L226 are depicted as red tubes with black labels. Panels c−l show the glycosidic torsional angle maps for LSTc and LSTa in the bound
state with H7 sampled by MD simulation; the population is represented by color-coded 2D histograms. Each pair of ϕi and ψi is split in small but
ﬁnite elements of area (hexagonal), whose color is proportional to the population of each element (torsional state). This approach localizes the most
probable conformations as “clusters” of states (from yellow to red), surrounded by less populated (from cyan to blue). From panel c to l, by graphical
inspection, the most probable glycosidic torsional states of the LSTc:H7 and LSTa:H7 complexes are determined with an uncertainty of ≥15°.
Dihedral angles of the corresponding glycans determined by Eisen et al.19 (H3N2), Shi et al.14 (4KOM and 4KON), and Xiong et al.13 (4BSE and
4BSF) are indicated by black segments.
Figure 4. Complexes (a) LSTc:H7, (b) LSTc:H7sm, (c) LSTa:H7, and (d) LSTa:H7sm were reported, superimposing 15 poses of the MD
simulation trajectories from 0 to 150 ns sampled in steps of 10 ns. HA was superimposed on its protein backbone (Cα), reported in ribbon
representation only for times 0 and 150 ns. The white and orange ribbons correspond to HA sequences free to move and backbone restrained (see
Materials and Methods) by soft harmonic potential, respectively. The red tubes and black labels show selected residues of the H7 RBS bottom.
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363 mutation, even though a weak preference for the avian form
364 could be deduced in glycan microarray and kinetic tests.
365 Molecular Dynamics Simulation of Complexes of
366 LSTa and LSTc with H7. MD Simulation and 1H STD
367 Glycan Binding Epitope Comparison. MD simulations of the
368 glycan−HA complexes were used to adapt the conformation
369 and relative position of binding of LSTa and LSTc to H7, to the
370 water solution environment, and to introduce dynamic aspects
371 of the glycan−HA interaction, complementing the glycan
372 binding epitope mapped by 1H STD spectra. The MD
373 simulation of LSTa:H7 and LSTc:H7 complexes conﬁrmed
374 that Neu5Ac was the primary interacting residue for both
f3 375 glycans (Figure 3a,b). In fact, for the whole simulation
376 (approximately 150 ns), Neu5Ac maintained its starting
377 position at the bottom of H7 RBS, among the conserved
378 residues Y98, W153, H183, L194, and Y195 (H3 numbering),
379 in strict agreement with the corresponding X-ray-resolved
380 three-dimensional (3D) structures,3,13,14 and with the 1H STD
381 binding epitope. In the LSTc:H7 complex, the RMSDs between
382 Neu5Ac and Gal-1 from their X-ray structures oscillate around
383 values of <1 and 2 Å, respectively (Figure S2, left, black and red
384 lines), while in the LSTa:H7 complex, the corresponding
385 RMSD values ﬂuctuate around 2 Å. The simulated GlcNAc
386 residue show less agreement with the X-ray structure, but if in
387 the LSTc:H7 complex, GlcNAc shows wide ﬂuctuations in
388 RMSD around the average value of 7 Å without convergence, in
389 the LSTa:H7 complex, the RMSD of GlcNAc decreases slowly
390 (Figure S2, green lines). These results support for GlcNAc an
391 interaction weaker than that of LSTc nonreducing end
392 disaccharide, Neu5Ac α(2−6) Gal-1. In contrast, GlcNAc in
393 the LSTa:H7 complex slowly converges to a conformation and
394 relative position approximately 4 Å from the corresponding X-
395 ray structure, suggesting that, in this case, GlcNAc binds H7
396 RBS with a strength comparable to that of the LSTa
397 nonreducing end residues, Neu5Ac and Gal-1. The Neu5Ac
398 positions in H7 RBS were found to be similar for both LSTa
399 and LSTc, as reported previously for H3 and H5 HA.19,28 This
400 can be seen in Figure S3 for models of the LSTc:H7 and
401 LSTa:H7 complexes in which the two Neu5Ac residues are
402 superimposed over the protein backbone of hemagglutinin.
403 LSTa showed interaction with H7 RBS employing all its
404 residues from Neu5Ac to Glc, occupying the space between
405 loop 220 and helix 190, corresponding to an unusual binding
406 epitope for an avian-like receptor in the bound state with HA,
407 such as H1, H3, and H5, where the LSTa reducing end
408 protrudes vertically (HA trimer axis) from the RBS.8,9,19,27,28
409 MD simulation of the LSTa:H7 complex showed clearly how
f4 410 LSTa left its vertical position (Figure 4c, wide tube) quite early
411 (after ∼30 ns), maintaining its contacts until the end of the MD
412 simulation (Figure 3b). In the LSTa:H7 interaction, the 1H
413 STD binding epitope included recognized signals from
414 Neu5Ac, Gal-1, and Gal-2, while no proton signal belonging
415 to GlcNAc was detected. In another way, the MD simulation
416 description of the LSTa:H7 complex suggests probable contacts
417 between parts of the GlcNAc residue and H7 RBS (loop 220).
418 Overall qualitative agreement between 1H STD basic restraints
419 and the MD-simulated LSTa:H7 could be evinced from Figure
420 3b. In contrast, the LSTc binding epitope corresponds to
421 Neu5Ac and Gal-1 residues, while the remainder showed longer
422 distances with H7 RBS residues; in fact, the methyl protons of
423 GlcNAc were not seen in 1H STD spectra, in agreement with
424 the conelike surfaces spanned by the LSTc reducing end as
425 predicted by MD simulation (Figures 3a and 4a). This behavior
426was hypothesized by Chandrasekaran et al.6 for Neu5Ac α(2−
4276) Gal-1-terminated glycans longer than three residues but was
428not observed in the LSTc:H1 complex (SC18) over a
429comparable simulation time scale, as described below.
430Glycosidic Linkage Dihedral Angle Analysis. The Ram-
431achandran plots of the glycosidic linkages of LSTc:H7 and
432LSTa:H7 complexes sampled by MD simulation are reported in
433Figure 3c−l. The torsional angle pair of ϕ1 and ψ1 correspond
434to the Neu5Ac Gal-1 glycosidic bond, deﬁned by four
435consecutive atoms: C1−C2−O6−C6/C2−O6−C6−C5 for
436LSTc and C1−C2−O3−C3/C2−O3−C3−H3 for LSTa. The
437remaining pairs of ϕi and ψi (i = 2 or 4) involve atoms H1−
438C1−O3−C3/C1−O3−C3−H3 or H1−C1−O4−C4/C1−
439O4−C4−H4 for each remaining glycosidic junction, including
4401→3 or 1→4 connectivity. The ω angle in LSTc is deﬁned by
441the O6−C6−C5−H5 atoms of the Gal-1 residue. All these
442dihedral angles are deﬁned in accord with Xu et al.29 In
443particular, for the LSTc:H7 complex, the most probable state
444for ϕ1 and ψ1 is a cluster centered at approximately −60 ± 180°
445(Figure 3c), where the symbol ± indicates that the angle ψ1
446populates a state characterized by values approaching 180°
447(trans) from the left and from the right side of this limit.
448Ramachandran plots of LSTc and LSTa in the bound state with
449H7 show diﬀerences at ϕ1 and ψ1 and at ϕ2 and ψ2, in the
450position of the most probable states and the width of their
451distribution, while ϕ3 and ψ3 and ϕ4 and ψ4 are comparable.
452This correlates for both glycans with an asymmetric binding
453epitope, with stronger contacts at their nonreducing end. The
454greater degree of conformational freedom of LSTc in the
455bound state with H7, not observed for LSTa, corresponds to a
456wider distribution of ψ1 (Figure 3c,g), while the ω angle
457contributes to population of two states, located at approx-
458imately −54° and ±160°, of which the former is dominant
459(98%) compared to the latter (2%). Previous structural data for
460the LSTc:H118 and LSTc:H319 complexes indicate only a value
461allowed for ω (−60°), in agreement with the value of −49°
462measured in MD simulation for the LSTc:H1 complex (SC18).
463The Ramachandran plots in Figure 3 qualitatively match the
464dihedral angles determined by X-ray analysis of the
465corresponding glycans in the bound state with H3 (X31
466inﬂuenza A, H3N2) by Eisen et al.19 and H7 (H7N9) by Shi et
467al.14 and Xiong et al.13
468Molecular Dynamics Simulations of Complexes
469between LSTa or LSTc and H7sm: Eﬀect of the
470H7G228S Mutation on the Interaction of H7 with the
471Human or Avian Receptor. MD simulations of the
472LSTa:H7sm and LSTc:H7sm complexes were compared to
473those of the previously discussed LSTa:H7 and LSTc:H7
474complexes to observe binding epitope and dynamic changes
475upon H7 mutation (G228S), possibly indicating changes to H7
476speciﬁcity. The LSTa:H7 and LSTc:H7 model complexes
477allowed analysis of the H7 RBS at atomic precision, visualizing
478the way in which the G228S mutation potentially introduces an
479additional hydrogen bond between H7 RBS and the sialyl tail,
480C7−C8−C9 of Neu5Ac in both glycans (Figure S4a). Even
481though, instinctively, this mutation should be expected to
482reinforce the binding interaction of both glycans at the level of
483Neu5Ac, possibly correlated to a widening of the H7 RBS,28 its
484eﬀects on the glycan binding epitope and on dynamic aspects of
485the interaction cannot easily be predicted. The possibility of
486building models of LSTa:H7sm and LSTc:H7sm complexes by
487“mutating virtually” one amino acid from the previously
488analyzed LSTa:H7 and LSTc:H7 complexes, leaving the rest
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489 unchanged in both sequence and conformation, allowed
490 signiﬁcant diﬀerences in the MD simulation trajectories to be
491 correlated with the mutation. In particular, LSTa interacting
492 with H7sm showed weak improvement in LSTa reducing end
493 contacts toward the protein, compared to the case for H7. This
494 observation was supported by the distance histograms
495 calculated by MD simulation, exhibiting distances between
496 H2 Glc and protons surrounding the RBS shorter than those of
497 wild type H7 (Figure S4b, right). Similar behavior was observed
498 for the distances between the methyl protons of GlcNAc and
499 the protons surrounding the H7 RBS in the LSTc:H7sm
500 complex, where a greater population of shorter distances was
501 found in comparison to that of the LSTc:H7 complex (Figure
502 S4c, right). This ﬁnding was conﬁrmed also by STD
503 experiments, where the STD signal of the methyl group
504 belonging to GlcNAc, not seen in interaction with H7, became
505 weakly visible upon interaction with H7sm, indicating a
506 stronger contact between the LSTc reducing end and helix
507 190 (Figures 1 and 2d). Similarly, the H2 Gal-1 of LSTc was
508 found closer to the surface of H7sm than H7, as can be
509 observed by the corresponding histograms in the interval
510 between 2.5 and 15 Å (Figure S4c, left).
511 Via comparison of the MD simulations of the four
512 LSTc:H7sm, LSTc:H7, LSTa:H7sm, and LSTa:H7 complexes,
513 considerable diﬀerences between glycan mobility in binding of
514 H7 or H7sm were detected. In the case of LSTc bound to
515 H7sm, a narrower region of conformational space was sampled
516 than for LSTc binding H7 on the same time scale (from 0 to
517 150 ns), while its nonreducing end disaccharide appeared in
518 both cases to interact with the bottom of the RBS with a greater
519 or comparable strength (Figure 4a,b). Furthermore, LSTa
520 binding H7sm appears to be less mobile at the reducing end, in
521 comparison to the LSTa:H7 complex (Figure 4c,d). For LSTa
522 and LSTc, Neu5Ac appears to be strongly bound to HA RBS in
523 both mutated and unmutated versions. Interestingly, this
524 describes for both LSTc and LSTa how the H7G228S
525 mutation, localized near the glycan nonreducing end, induces
526 a lower mobility at the glycan reducing end (Figure 4). The
527 comparison of ligand mobility in H7 RBS before and after
528 mutation can be described by plotting the “distance” (RMSD)
529 of each ligand pose from their reference (time zero) as a
530 function of time interval, after superimposition of the protein
f5 531 backbone in all the analyzed snapshots (Figure 5). Comparing
532 the estimated slopes and values of the RMSD functions for
533 LSTc and LSTa in the bound state with H7 or H7sm explained
534how the G228S mutation reduces the mobility for both glycans,
535even though it was slightly more evident for LSTa. To consider
536the eﬀects of structure relaxation of the tested complexes on
537ligand mobility, particularly evident at the beginning of the
538simulation, Figure S5 reports the RMSD functions calculated
539for LSTc and LSTa as in Figure 5, but used as a reference the
540snapshot at 80 ns, corresponding to approximately halfway
541through the MD trajectories. Interestingly, Figure S5 and
542Figure 5 suggest how the mobilities of LSTa and LSTc in the
543bound state with H7sm were smaller in comparison to those of
544the corresponding complexes that included the wild type form
545of H7. In conclusion, no indication of a signiﬁcant switch in H7
546preference toward LSTc (human receptor) was observed, in
547contrast to H2 and H3 subtypes, but in agreement with Young
548et al.16 and Schrauwen et al.17
549The glycosidic torsional angle mobility of LSTa and LSTc in
550the bound state with H7sm and H7 could be compared,
551revealing interesting details regarding the distinct ability of
552H7sm and H7 to bind (constrain) the two glycans. Figure S6
553shows how the lower mobility of LSTc binding H7sm
554compared to H7 was localized at ϕ1 and ψ1 torsional angles,
555corresponding to the nonreducing end disaccharide Neu5Ac
556α(2−6) Gal-1, as seen by its narrower distribution in Figure
557S6e. In contrast, LSTa in the bound state with H7sm showed a
558signiﬁcantly narrower distribution extending on two angle pairs,
559ϕ1 and ψ1 and ϕ2 and ψ2, and distinct torsional states at ϕ3 and
560ψ3, in comparison to the LSTa:H7 complex (Figure S6a−c,e−
561h). These results conﬁrm stronger binding by H7sm to both
562glycans, even if LSTa appears to be more restrained than LSTc,
563agreeing with the ligand mobility analysis using the RMSD
564function shown above.
565Comparison of the Interaction between LSTc with H1
566and LSTc with H7 Assessed by 1H STD and MD
567Simulation: H1 and H7 Exhibit Distinct Modes of
568Binding to the Human Glycan Receptor. Shi et al.14
569showed strong diﬀerences in the binding speciﬁcity of the
570hemagglutinin H1 (CA04-H1N1 A/California/04/2009
571H1N1) and H7 (AH-H7N9) toward glycan cell surface
572receptors: the former being speciﬁc for LSTc (human) and
573the latter showing an ability to bind LSTc and LSTa with
574similar aﬃnity and corresponding to low speciﬁcity. In a
575previous publication, our group analyzed structurally LSTc and
576LSTa interacting with H1 (H1N1 South Carolina 1918) and
577selected mutants.8 This analysis based on 1H STD NMR and
578MD simulation provided a structural interpretation of a H1
Figure 5. RMSD (root-mean-square distance) of (a) LSTc and (b) LSTa in the bound state with H7 (black) and H7sm (red) at diﬀerent simulation
times using as a reference the ligand conformation at time zero, calculated for the complex structures in Figure 4 after superimposition of the
hemagglutinin backbone.
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579 speciﬁcity switch in LSTc and LSTa driven by H1 RBS
580 mutations. Via comparison of 1H STD spectra of LSTc in the
f6 581 bound state with those of H1 and H7 (Figure 6, green and
582 black lines, respectively), diﬀerent binding epitopes became
583 visible. LSTc interacts with H7 mainly through Neu5Ac and
584 Gal-1 (H1 and H4), while in the LSTc:H1 interaction, Neu5Ac
585 was the residue of primary interest but the four remaining
586 monosaccharides were also involved: H1 and H4−H6 of Gal-1,
587 CH3 of GlcNAc, H4 of Gal-2, and H5 and H6 of Glc. The
588 greater number of protons belonging to LSTc detected in these
589 spectra in comparison to the number for the LSTc:H7 complex
590 supports qualitatively higher “ligand receptor” aﬃnity in the
591 former case, as measured by Shi et al.14 using a biochemical test
592 (glycan array). Via comparison of the MD simulation
593 trajectories of LSTc:H1 and LSTc:H7 complexes, some
594 structural features of H1 and H7 RBS could be related to
f7 595 their diﬀerent LSTc recognition abilities. Figure 7 shows how
596 the LSTc reducing end (Gal-1 GlcNAc Gal-2 Glc) was closer to
597 helix 190 in the LSTc:H1 complex (green tubes and cyan
598 ribbon) than in the LSTc:H7 complex (purple tube and white
599 ribbon), while the Neu5Ac position was comparable in both
600 complexes. This diﬀerence in the LSTc binding epitope was
601 mainly related to a longer loop 150, characteristic of H7, which
602 disturbed the short-range interactions between the LSTc
603 reducing end and helix 190 and, hence, supported the weaker
604 binding.2,13,14 Several residues additionally contribute to the
605 higher aﬃnity of H1 for LSTc, such as D190 (helix 190) and
606 the pair of K222 and D225 (loop 220) in H1, E190, and the
607 pair Q222 of G225 in H7. As described previously by Elli et al.,8
608 the fact that D190 has a side chain shorter than that of E190
Figure 6. 1H STD spectra of LSTc interacting with H1 (H1N1 SC18) (green) and with H7 (H7N9 A/Anhui/1/13) (black). The STD spectra are
superimposed on the 2D HSQC spectra of LSTc (black contour lines). Protons detected through STD are labeled in red for the LSTc:H1
interactions.
Figure 7. LSTc:H1 and LSTc:H7 complexes represent superimposed
snapshots at simulation times of 150 ns of the corresponding MD
simulations. LSTc in the bound state with H1 (green tubes for carbon
atoms) and LSTc in the bound state with H7 (purple tubes for carbon
atoms) at simulation times of 50, 100, and 150 ns are represented by
thin, medium, and wide tubes, respectively. H1 and H7 are
represented by cyan and white ribbons, respectively, superimposed
on the helix 190 protein backbone (Cα). Loop 150, longer in H7
(white ribbon) than in H1 (light blue ribbon), is visible on the top of
helix 190.
Biochemistry Article
DOI: 10.1021/acs.biochem.6b00693
Biochemistry XXXX, XXX, XXX−XXX
I
609 favored the LSTc reducing end contact with helix 190 (Figure 7
610 and Figure S7), while the pair of K222 and D225 in H1 bound
611 Gal-1 to loop 220 more strongly than did Q222 and G225 of
612 H7 (Figure S7), considering the possible electrostatic
613 interactions characteristic of the former pair of residues.
614 The L226 residue, instead of Q226, widens the HA RBS, as
615 observed between the two variants AH-H7N9 and SH-H7N9,
616 having L226 and Q226, respectively.13,14 MD simulation
617 reproduces an H7 RBS wider and more ﬂexible than H1,
618 visualized by greater distances between loop 130 and loop 220
619 as reported in Figure S8; these results were also conﬁrmed by
620 the corresponding 3D crystal structure complexes (PDB entries
621 4BSE and 2WRG). At the bottom of helix 190, the larger
622 hydrophobic V186 (H7) in comparison to P186 (H1) reduces
623 the size of the space to accommodate the Neu5Ac and its sialyl
624 tail (Figure S7c,d), contributing to the larger distances between
625 LSTc and helix 190 when binding H7 and then H1, as observed
626 previously by Xiong et al.13
627 Comparing the glycosidic junction conformation of the
628 LSTc:H7 and LSTc:H1 (SC18) complexes (Figure S9), we ﬁnd
629 signiﬁcant diﬀerences are located at ϕ1 and ψ1 and at ϕ2 and ψ2,
630 while ϕ3 and ψ3 and ϕ4 and ψ4 are more similar. In the
631 LSTc:H7 and LSTc:H1 complexes, ϕ1 is centered at −60°, but
632 the former complex has a slightly wider distribution, showing a
633 poorly populated state around 60°; ψ1 has a wider dispersion in
634 the LSTc:H7 complex with a main state centered at ±180° and
635 a secondary state at 90°. At ϕ2 and ψ2, the LSTc:H1 complex
636 populates only one state centered at 60°/0° in comparison to
637 the LSTc:H7 complex, where two allowed conformations are
638 located (30°/−30° and −30°/−30°) (Figure S9 and Table S1).
639 Comparing the LSTc:H7 and LSTc:H1 complexes in terms of
640 the number of states and distribution width at ϕ1 and ψ1, ϕ2
641 and ψ2, and ω (Figure S9, ω not reported), we ﬁnd H7 appears
642 to constrain LSTc less eﬃciently than H1. In fact, for the
643 binding of LSTc to H1, the nonreducing end interaction with
644 the bottom of the HA RBS is reinforced by the interaction
645 between the LSTc reducing end (GlcNAc) and helix 190
646 (D190, L194), particularly favored by the bent shape of LSTc,
647 as described by Elli et al.8 The ϕ1/ψ1 conformation of the
648 LSTa:H7 complex centered at −60°/−30° is closer to that of
649 LSTa:H1 (NY18) (−60°/0°),8 LSTa:H3 (−68°/−18°),19 or
650 LSTa in the free state (−62°/−8°)7 than to that observed for
651 LSTa:H1 (AV18) (−150°/−30°).8 These structural and
652 dynamic details indicate a lower aﬃnity of LSTc for H7 than
653 for H1, as observed by Shi et al.14
654 ■ DISCUSSION
655 This work, considering both structural and dynamic aspects,
656 improved our understanding of the molecular mechanisms by
657 which the H7 hemagglutinin of the new inﬂuenza A virus
658 H7N9 recognizes human and avian glycan receptors. The
659 combination of experimental NMR spectroscopic techniques
660 and MD simulations used in this study provided structural and
661 dynamic information that cannot be fully revealed by the static
662 X-ray diﬀraction description, because of the high ﬂexibility of
663 glycans,2 and cannot be described by a single snapshot image of
664 a glycan−HA complex. The previously incompletely charac-
665 terized interaction between glycan receptors and wild type H7
666 (AH-H7N9 variant) and a biologically relevant mutant
667 (G228S), supposed to switch the H2 and H3 preference
668 from avian (LSTa) to human (LSTc) receptors, was studied.
669 The 1H STD/MD approach indicates that LSTa and LSTc
670 interact with H7 using diﬀerent binding epitopes, even if
671Neu5Ac occupies exactly the same position in both glycans, as
672previously observed for other HA subtypes such as H3 and
673H5.19,28 In particular, LSTa binds H7 with Neu5Ac, Gal-1, Gal-
6742, and possibly GlcNAc, adapting its extended shape to the
675valley between loop 220 and helix 190, a less usual binding
676epitope for this glycan compared to other subtype HAs, such as
677H1, H3, and H5,8,9,19,27,28 in which the reducing end of LSTa
678emerges from the HA RBS vertically, allowing Gal-1 and
679GlcNAc to interact with helix 190 (E190). The LSTc binding
680epitope involves mainly Neu5Ac and Gal-1, although its
681reducing end (GlcNAc Gal-2 Glc) showed an interaction
682propensity that was weaker than the binding observed in the
683LSTc:H1 (SC18) complex in the previous MD simulation
684study. In fact, LSTc:H7, distinct from LSTc:H1, reproduces the
685“umbrella-like” conformations over a time scale of 150 ns as
686proposed by Chandrasekaran et al.,6 which correspond to an
687overall wider distribution of the dihedral angles: ϕ1 and ψ1, ω,
688and, ϕ2 and ψ2. Particularly for their nonreducing end
689disaccharide, this description matches the X-ray 3D structures
690of α(2−3) and α(2−6) lactosamine in complexes with H713
691used as references throughout the entire MD simulation. The
692same approaches were applied to predict the ability of LSTa
693and LSTc to bind the H7G228S mutant, comparing the
694structural and dynamic properties of the interaction with those
695of the wild type version of the protein. 1H STD spectra showed
696a binding epitope slightly diﬀerent from the corresponding
697epitope, indicating that the selected mutation does not aﬀect
698signiﬁcantly the relative aﬃnity of H7 for one of the two
699ligands. The comparison of the MD simulation trajectories
700between the model complexes, LSTa:H7sm, LSTc:H7sm with
701LSTa:H7, and LSTc:H7, suggests that the G228S mutation
702allows H7sm to bind both glycans with a strength greater than
703that of the wild type version of H7, even if this reinforcement
704appears to be more eﬃcient for LSTa. This result, supported by
705preliminary 1H STD competition experiments, suggests that the
706selected mutation does not switch the H7 preference toward
707the human glycan receptors, in contrast to similar H2 and H3
708subtypes, but is in agreement with glycan arrays and kinetic
709results for H7 of the SH-H7N9 virus16 and the previously
710published solid phase binding assays on H7 of the AH-H7N9
711variant.17
712This work allows also the comparison of H1 (SC18) and H7
713(AH-H7N9) RBS in the bound state with LSTc, highlighting
714the structural details that underlie the diﬀerences in aﬃnity
715toward this model of the human receptor. 1H STD showed that
716H1 binds LSTc using all ﬁve residues, while H7 employs only
717two of the ﬁve residues (Neu5Ac and Gal-1). Additionally the
718glycosidic dihedral angle distribution analysis revealed a lower
719mobility for LSTc in the bound state with H1 in comparison to
720that with H7, supporting the greater strength of binding of H1
721to this glycan. The structural and dynamic comparison between
722the RBS of H1 and H7 revealed crucial diﬀerences in loop 150,
723helix 190, and loop 220, possibly explaining their aﬃnity
724diﬀerence toward the human receptor represented by LSTc,
725previously determined by biochemical assays, and statically by
726X-ray-based structural investigation.
727The application of three complementary approaches, X-ray
728diﬀraction, NMR, and MD simulation, to the structural and
729dynamic characterization of glycan−HA interactions allowed
730improvements in the comprehension of the molecular
731mechanisms behind HA recognition events. All these structural
732and dynamic aspects are important to the design of antiviral
733drugs targeting HAs but also for predicting those mutations
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734 that could improve HA speciﬁcity for human receptors, a factor
735 at the base of the potential pandemic diﬀusion of an emerging
736 virus.
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